McDade C - Search Results

1

Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.

Zimmer L, McDade C, Beyhaghi H, Purser M, Textoris J, Krause A, Blanc E, Pavlov V, Earnshaw S. Zimmer L, et al. Among authors: mcdade c. J Neurotrauma. 2023 Apr;40(7-8):706-719. doi: 10.1089/neu.2022.0270. Epub 2022 Nov 28. J Neurotrauma. 2023. PMID: 36267001 Free PMC article.

2

Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.

Earnshaw SR, Klok RM, Iyer S, McDade C. Earnshaw SR, et al. Among authors: mcdade c. Aliment Pharmacol Ther. 2010 Apr;31(8):911-21. doi: 10.1111/j.1365-2036.2010.04244.x. Epub 2010 Jan 20. Aliment Pharmacol Ther. 2010. PMID: 20096019

3

Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations.

Earnshaw SR, McDade CL, Black LK, Bell CF, Kattan MW. Earnshaw SR, et al. Pharmacoeconomics. 2010;28(6):489-505. doi: 10.2165/11531780-000000000-00000. Pharmacoeconomics. 2010. PMID: 20196623

4

Cost-utility of aspirin and proton pump inhibitors for primary prevention.

Earnshaw SR, Scheiman J, Fendrick AM, McDade C, Pignone M. Earnshaw SR, et al. Among authors: mcdade c. Arch Intern Med. 2011 Feb 14;171(3):218-25. doi: 10.1001/archinternmed.2010.525. Arch Intern Med. 2011. PMID: 21325111 Free PMC article.

5

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial.

Kattan MW, Earnshaw SR, McDade CL, Black LK, Andriole GL. Kattan MW, et al. Appl Health Econ Health Policy. 2011 Sep 1;9(5):305-15. doi: 10.2165/11592200-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21875161

6

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.

Earnshaw SR, McDade CL, Zanotti G, Farkouh RA, Strutton D. Earnshaw SR, et al. BMC Infect Dis. 2012 Apr 24;12:101. doi: 10.1186/1471-2334-12-101. BMC Infect Dis. 2012. PMID: 22530841 Free PMC article.

7

Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.

Earnshaw SR, McDade C, Chapman AM, Jackson D, Schwamm L. Earnshaw SR, et al. Among authors: mcdade c. Clin Ther. 2012 Jul;34(7):1544-58. doi: 10.1016/j.clinthera.2012.05.004. Epub 2012 Jun 12. Clin Ther. 2012. PMID: 22695225

8

Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges.

Earnshaw SR, Brogan AP, McDade CL. Earnshaw SR, et al. Pharmacoeconomics. 2013 Apr;31(4):289-304. doi: 10.1007/s40273-013-0037-6. Pharmacoeconomics. 2013. PMID: 23519744 Review.

9

Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men.

Pignone M, Earnshaw S, McDade C, Pletcher MJ. Pignone M, et al. Among authors: mcdade c. J Gen Intern Med. 2013 Nov;28(11):1483-91. doi: 10.1007/s11606-013-2465-6. Epub 2013 May 17. J Gen Intern Med. 2013. PMID: 23681842 Free PMC article.

10

Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.

Pletcher MJ, Pignone M, Earnshaw S, McDade C, Phillips KA, Auer R, Zablotska L, Greenland P. Pletcher MJ, et al. Among authors: mcdade c. Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):276-84. doi: 10.1161/CIRCOUTCOMES.113.000799. Epub 2014 Mar 11. Circ Cardiovasc Qual Outcomes. 2014. PMID: 24619318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters